Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
62.94
-0.20 (-0.32%)
At close: Dec 5, 2025

SHA:688192 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
29,02717,23719,53016,03014,959-
Upgrade
Market Cap Growth
47.58%-11.74%21.83%7.16%--
Upgrade
Enterprise Value
28,16617,34218,89114,51814,805-
Upgrade
Last Close Price
62.9441.4747.8539.3737.01-
Upgrade
PS Ratio
47.7647.89213.94-1454.37-
Upgrade
PB Ratio
20.1186.1623.019.126.07-
Upgrade
P/TBV Ratio
28.03-50.5112.667.53-
Upgrade
EV/Sales Ratio
46.3548.18206.94-1439.37-
Upgrade
Debt / Equity Ratio
0.745.790.480.050.04-
Upgrade
Asset Turnover
0.260.220.05-0.010.03
Upgrade
Inventory Turnover
0.810.350.54---
Upgrade
Quick Ratio
2.381.111.785.709.825.88
Upgrade
Current Ratio
2.471.272.035.939.966.06
Upgrade
Return on Equity (ROE)
-92.82%-179.21%-84.98%-34.87%-37.83%-76.72%
Upgrade
Return on Assets (ROA)
-24.53%-37.70%-40.35%-20.52%-21.46%-52.76%
Upgrade
Return on Capital (ROIC)
-29.32%-46.33%-46.54%-22.54%-23.23%-62.42%
Upgrade
Return on Capital Employed (ROCE)
-43.10%-103.90%-110.20%-43.20%-26.60%-70.80%
Upgrade
Earnings Yield
-2.99%-4.91%-5.67%-4.59%-4.48%-
Upgrade
FCF Yield
-2.77%-4.57%-5.12%-4.22%-3.35%-
Upgrade
Buyback Yield / Dilution
-5.52%-1.83%-0.70%-12.29%-0.07%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.